FDA Inspection 1037398 — Eagle Distributors Inc.

Eagle Distributors Inc. — FEI 3003764156

The FDA completed an inspection of Eagle Distributors Inc. on Jan 11, 2018 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 11, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
187921 CFR 211.180(c)Records not made readily available to FDA
194221 CFR 211.180(e)Records reviewed annually
200821 CFR 211.186(a)Written procedures followed
201921 CFR 211.188(b)(7)Documentation of Actual Yield and Theoretical Yield
440121 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.